# FDA Inspection 1014007 - GraftSource, LLC. - January 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/graftsource-llc/a6a50210-8010-446b-92e4-5566a5934f2f
Source feed: FDA_Inspections

> FDA Inspection 1014007 for GraftSource, LLC. on January 19, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014007
- Company Name: GraftSource, LLC.
- Inspection Date: 2017-01-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277702 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/graftsource-llc/400495a6-6222-4aeb-b7d5-1b85e572ec27)
- [FDA Inspection 1277702 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/graftsource-llc/6f1f6056-f03a-4efa-90bc-06d6fc312709)
- [FDA Inspection 882810 - 2014-06-12](https://www.keypedia.com/records/fda_inspections/graftsource-llc/4e760eeb-6ae8-46f7-a99a-d917fb67446e)

Company: https://www.keypedia.com/companies/graftsource-llc/42f401cc-85b1-4eb8-8fcf-8527b27a5923

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d